Speech-Language Pathologists in Portland, IN Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Jeanne K Mcmillan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7270 E 300 N, Portland, IN 47371 Phone: 765-285-8176

Mr. Clifton James Derome Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1267 W Deer Haven Dr, Portland, IN 47371 Phone: 260-726-7394    Fax: 260-726-2941

Lindsey Peterson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 W Main St, Portland, IN 47371 Phone: 260-703-0267

News Archive

Study identifies small loop in human prion protein that resists chronic wasting disease

Chronic wasting disease (CWD) — an infectious disease caused by prions — affects North American elk and deer, but has not been observed in humans. Using a mouse model that expresses an altered form of the normal human prion protein, researchers at University of California, San Diego School of Medicine have determined why the human proteins aren't corrupted when exposed to the elk prions.

A20 protein plays protective role in diseases associated with chronic bowel inflammation: Scientists

Scientists associated with VIB (Flanders Institute for Biotechnology) and Ghent University have discovered that A20 protein plays an important protective role in diseases associated with chronic bowel inflammation. This makes A20 into a promising therapeutic target for the development of new anti-inflammatory drugs.

UCLA pediatrician receives 2012 Nemours Child Health Services Research Award

Dr. Tumaini Rucker Coker, assistant professor of pediatrics at the David Geffen School of Medicine at UCLA and Mattel Children's Hospital UCLA was honored with the 2012 Nemours Child Health Services Research Award at the Academy Health annual research meeting in Orlando on June 23.

New initiative aimed at reducing the excessively high rates of stroke

U.S. Department of Health & Human Services has announced approximately $2 million in grant awards to support a new initiative aimed at reducing the excessively high rates of stroke, stroke disabilities and stroke deaths that disproportionately occur in the southeastern region of the United States.

Researchers are developing and testing novel gene therapy to cure Crigler-Najjar syndrome

Crigler-Najjar syndrome affects about one in a million people at birth. Because of a defective gene, these individuals lack an essential enzyme in their liver to eliminate bilirubin, a toxic bile pigment that accumulates in all body tissues causing jaundice and potentially leading to irreversible and lethal neurological damage.

Read more Medical News

› Verified 9 days ago